Tomita, Mariko

Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. [electronic resource] - International journal of cancer Feb 2006 - 765-72 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication

0020-7136

10.1002/ijc.21389 doi


Adult
Animals
Antineoplastic Agents--therapeutic use
Apoptosis--drug effects
CDC2 Protein Kinase--metabolism
Cell Cycle--drug effects
Cell Cycle Proteins--metabolism
Cell Proliferation--drug effects
Curcumin--therapeutic use
Cyclin D1--metabolism
Female
Gene Products, tax--pharmacology
Human T-lymphotropic virus 1--drug effects
Humans
Inhibitor of Apoptosis Proteins
Leukemia, T-Cell--drug therapy
Leukemia-Lymphoma, Adult T-Cell--drug therapy
Mice
Mice, Inbred ICR
Mice, SCID
Microtubule-Associated Proteins--metabolism
NF-kappa B--antagonists & inhibitors
Neoplasm Proteins--metabolism
Survivin
T-Lymphocytes--drug effects
Tumor Cells, Cultured
X-Linked Inhibitor of Apoptosis Protein--metabolism
cdc25 Phosphatases--metabolism